Validation, Calibration, and Standardization in the Life Sciences Market

Description

List of Tables

The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.

The North American market for validation, calibration, and standardization in life sciences was valued at $1.1 billion in 2025 and is estimated to reach $1.6 billion by 2030, at a CAGR of 6.8% from 2025 through 2030.

The Asia-Pacific market for validation, calibration, and standardization in life sciences was valued at $698.2 million in 2025 and is estimated to reach $997.2 million by 2030, at a CAGR of 7.4% from 2025 through 2030.

Report Scope

The report analyzes the trends in the global market for validation, calibration, and standardization in life sciences. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The market is segmented by service provider (in-house, third-party, original equipment manufacturer (OEM)), service type (electrotechnical, mechanical, thermal, pressure, pipette, fluid flow/optical, others), product type, and end user. Product type consists of instruments and consumables. Instruments are further segmented into biochemistry analyzers, pH meters, pressure and temperature calibrators, and conductivity meters. Consumables are segmented into calibration kits/sampling kits, glassware, filters, slides, and other items. End users consist of pharmaceutical and biotech companies, research laboratories, contract research organizations, and clinics and hospitals. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the Rest of Europe, China, Japan, India, South Korea, and the Rest of Asia-Pacific.

The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. It offers company profiles that cover financials, product portfolios, and recent developments.

Report Includes

52 data tables and 48 additional tables
Overview and an analysis of the global markets for flexible printed circuit boards (FPCB) technology
Analyses of global market trends, with market revenue data for 2024, estimates for 2025, forecast for 2027, and projected CAGRs through 2030
Estimates of the size and revenue prospects for global flexible PCB market, along with a corresponding market share analysis by type, layer, application, end-use industry, and geographic region
Facts and figures about the global market dynamics, technological advancements, emerging applications, innovations, prospects, regulations, and the impact of macroeconomic factors
Insights derived from the Porter's Five Forces model, as well as global supply chain analyses
Analysis of patents, emerging trends and new developments in the electronics manufacturing industry
Analysis of the industry structure, including companies' market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG risk ratings scores and practices of leading companies
Company profiles of major players within the industry, including Thermo Fisher Scientific, SGS SA, Trescal, ValGenesis Inc., and Transcat Inc.

Product Code: BIO179B

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Analysis
Emerging Technologies
Conclusion

Chapter 2 Market Overview

Overview
Macroeconomic Factors
Porter's Five Forces Analysis

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Regulatory Compliance Requirements
Proliferation of Complex Biologics and Advanced Therapy Medicinal Products (ATMPs)
Digital Transformation and Industry 4.0 in Life Sciences
Market Restraints
High Cost Associated with Advanced Calibration Verification Solutions
Limited Availability of Specialized Technical and Regulatory Expertise
Market Opportunities
Digital Validation and Paperless Quality Systems
Adoption of Cloud-Based Good X Practice (GxP) Systems and Remote Validation Services

Chapter 4 Regulatory Landscape

Overview
U.S.
Europe
Asia-Pacific

Chapter 5 Emerging Technologies and Developments

Key Takeaways
AI-Driven Validation and Predictive Quality Platforms
Digital Validation Lifecycle Management Systems
IoT-Enabled Smart Calibration and Sensor-Based Monitoring
Cloud-Based Compliance Platforms and Remote Validation
Digital Twins for Validation and Bioprocess Standardization

Chapter 6 Market Segmentation Analysis

Overview
Segmentation Breakdown
Market Analysis by Service Provider
Key Takeaways
In-House
Third Party
OEM
Market Analysis by Service Type
Key Takeaways
Electrotechnical
Mechanical
Mechanical Testing Applications in Life Sciences
Thermal
Pressure
Pipette
Fluid Flow/Optical
Others
Market Analysis by Product Type
Key Takeaways
Instruments
Consumables
Market Analysis by End User
Key Takeaways
Pharmaceutical and Biotechnology Companies
Research Laboratories
Contract Research Organizations
Clinics and Hospitals
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World

Chapter 7 Competitive Intelligence

Key Takeaways
Competitive Analysis
Strategic Initiatives
Mergers and Acquisitions
Agreements, Collaborations, and Partnerships

Chapter 8 Appendix

Research Methodology
Sources
Abbreviations
Company Profiles
ADVANTEST CORP.
BECKMAN COULTER INC.
CROSS CO.
DASSAULT SYSTEMES
ENDRESS+HAUSER GROUP SERVICES AG
HARVARD BIOSCIENCE INC.
IBM CORP.
INSIGHT CALIBRATION SERVICES INC.
SGS Societe Generale de Surveillance SA
TEKTRONIX INC.
THERMO FISHER SCIENTIFIC INC.
TRANSCAT INC.
TRESCAL
VAISALA
VALGENESIS INC.

Product Code: BIO179B

List of Tables

Summary Table : Global Market for Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Table 1 : Global Market for Validation, Calibration, and Standardization in Life Sciences, by Service Provider, Through 2030
Table 2 : Global Market for In-House Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Table 3 : Global Market for Third-Party Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Table 4 : Global Market for OEM Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Table 5 : Global Market for Validation, Calibration, and Standardization in Life Sciences, by Service Type, Through 2030
Table 6 : Global Market for Electrotechnical Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Table 7 : Global Market for Mechanical Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Table 8 : Global Market for Thermal Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Table 9 : Global Market for Pressure Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Table 10 : Global Market for Pipette Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Table 11 : Global Market for Fluid Flow/Optical Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Table 12 : Global Market for Other Service Types of Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Table 13 : Global Market for Validation, Calibration, and Standardization in Life Sciences, by Product Type, Through 2030
Table 14 : Global Market for Instruments in Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Table 15 : Global Market for Instruments in Validation, Calibration, and Standardization in Life Sciences, by Product Type, Through 2030
Table 16 : Global Market for Consumables in Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Table 17 : Global Market for Consumables in Validation, Calibration, and Standardization in Life Sciences, by Product Type, Through 2030
Table 18 : Global Market for Validation, Calibration, and Standardization in Life Sciences, by End User, Through 2030
Table 19 : Global Market for Validation, Calibration, and Standardization in Life Sciences for Pharmaceutical and Biotechnology Companies, by Region, Through 2030
Table 20 : Global Market for Validation, Calibration, and Standardization in Life Sciences for Research Laboratories, by Region, Through 2030
Table 21 : Global Market for Validation, Calibration, and Standardization in Life Sciences for Contract Research Organizations, by Region, Through 2030
Table 22 : Global Market for Validation, Calibration, and Standardization in Life Sciences for Clinics and Hospitals, by Region, Through 2030
Table 23 : Global Market for Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Table 24 : North American Market for Validation, Calibration, and Standardization in Life Sciences, by Service Provider, Through 2030
Table 25 : North American Market for Validation, Calibration, and Standardization in Life Sciences, by Service Type, Through 2030
Table 26 : North American Market for Validation, Calibration, and Standardization in Life Sciences, by Product Type, Through 2030
Table 27 : North American Market for Validation, Calibration, and Standardization in Life Sciences, by End User, Through 2030
Table 28 : North American Market for Validation, Calibration, and Standardization in Life Sciences, by Country, Through 2030
Table 29 : European Market for Validation, Calibration, and Standardization in Life Sciences, by Service Provider, Through 2030
Table 30 : European Market for Validation, Calibration, and Standardization in Life Sciences, by Service Type, Through 2030
Table 31 : European Market for Validation, Calibration, and Standardization in Life Sciences, by Product Type, Through 2030
Table 32 : European Market for Validation, Calibration, and Standardization in Life Sciences, by End User, Through 2030
Table 33 : European Market for Validation, Calibration, and Standardization in Life Sciences, by Country, Through 2030
Table 34 : Asia-Pacific Market for Validation, Calibration, and Standardization in Life Sciences, by Service Provider, Through 2030
Table 35 : Asia-Pacific Market for Validation, Calibration, and Standardization in Life Sciences, by Service Type, Through 2030
Table 36 : Asia-Pacific Market for Validation, Calibration, and Standardization in Life Sciences, by Product Type, Through 2030
Table 37 : Asia-Pacific Market for Validation, Calibration, and Standardization in Life Sciences, by End User, Through 2030
Table 38 : Asia-Pacific Market for Validation, Calibration, and Standardization in Life Sciences, by Country, Through 2030
Table 39 : RoW Market for Validation, Calibration, and Standardization in Life Sciences, by Service Provider, Through 2030
Table 40 : RoW Market for Validation, Calibration, and Standardization in Life Sciences, by Service Type, Through 2030
Table 41 : RoW Market for Validation, Calibration, and Standardization in Life Sciences, by Product Type, Through 2030
Table 42 : RoW Market for Validation, Calibration, and Standardization in Life Sciences, by End User, Through 2030
Table 43 : Global Ranking of Companies in the Market for Validation, Calibration, and Standardization in Life Sciences, 2024
Table 44 : M&A in the Market for Validation, Calibration, and Standardization in Life Sciences, 2024 and 2025
Table 45 : Agreements and Partnerships in the Market for Validation, Calibration, and Standardization in Life Sciences, 2024-2025
Table 46 : Information Sources Used for this Report
Table 47 : Abbreviations Used in this Report
Table 48 : Advantest Corp.: Company Snapshot
Table 49 : Advantest Corp.: Financial Performance, FY 2023 and 2024
Table 50 : Advantest Corp.: Product Portfolio
Table 51 : Advantest Corp.: News/Key Developments, 2025
Table 52 : Beckman Coulter Inc.: Company Snapshot
Table 53 : Beckman Coulter Inc.: Product Portfolio
Table 54 : CROSS Co.: Company Snapshot
Table 55 : CROSS Co.: Product Portfolio
Table 56 : CROSS Co.: News/Key Developments, 2025
Table 57 : Dassault Systemes: Company Snapshot
Table 58 : Dassault Systemes: Financial Performance, FY 2023 and 2024
Table 59 : Dassault Systemes: Product Portfolio
Table 60 : Dassault Systemes: News/Key Developments, 2025
Table 61 : Endress+Hauser Group Services AG: Company Snapshot
Table 62 : Endress+Hauser Group Services AG: Financial Performance, FY 2023 and 2024
Table 63 : Endress+Hauser Group Services AG: Product Portfolio
Table 64 : Endress+Hauser Group Services AG: News/Key Developments, 2024 and 2025
Table 65 : Harvard Bioscience Inc.: Company Snapshot
Table 66 : Harvard Bioscience Inc.: Financial Performance, FY 2023 and 2024
Table 67 : Harvard Bioscience Inc.: Product Portfolio
Table 68 : Harvard Bioscience Inc.: News/Key Developments, 2024 and 2025
Table 69 : IBM Corp.: Company Snapshot
Table 70 : IBM Corp.: Financial Performance, FY 2023 and 2024
Table 71 : IBM Corp.: Product Portfolio
Table 72 : IBM Corp.: News/Key Developments, 2024
Table 73 : Insight Calibration Services Inc.: Company Snapshot
Table 74 : Insight Calibration Services Inc.: Product Portfolio
Table 75 : SGS Societe Generale de Surveillance SA: Company Snapshot
Table 76 : SGS Societe Generale de Surveillance SA: Financial Performance, FY 2023 and 2024
Table 77 : SGS Societe Generale de Surveillance SA: Product Portfolio
Table 78 : SGS Societe Generale de Surveillance SA: News/Key Developments, 2024 and 2025
Table 79 : Tektronix Inc.: Company Snapshot
Table 80 : Tektronix Inc.: Product Portfolio
Table 81 : Tektronix Inc.: News/Key Developments, 2023-2025
Table 82 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 83 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 84 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 85 : Thermo Fisher Scientific Inc.: News/Key Developments, 2025
Table 86 : Transcat Inc.: Company Snapshot
Table 87 : Transcat Inc.: Financial Performance, FY 2023 and 2024
Table 88 : Transcat Inc.: Product Portfolio
Table 89 : Transcat Inc.: News/Key Developments, 2023-2025
Table 90 : Trescal: Company Snapshot
Table 91 : Trescal: Product Portfolio
Table 92 : Trescal: News/Key Developments, 2024
Table 93 : Vaisala: Company Snapshot
Table 94 : Vaisala: Financial Performance, FY 2023 and 2024
Table 95 : Vaisala: Product Portfolio
Table 96 : Vaisala: News/Key Developments, 2024 and 2025
Table 97 : ValGenesis Inc.: Company Snapshot
Table 98 : ValGenesis Inc.: Product Portfolio
Table 99 : ValGenesis Inc.: News/Key Developments, 2024 and 2025

List of Figures

Summary Figure : Global Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Region, 2024
Figure 1 : Porter's Five Forces Analysis in the Global Market for Validation, Calibration, and Standardization in Life Sciences
Figure 2 : Market Dynamics of Validation, Calibration, and Standardization in the Life Sciences Industry
Figure 3 : Global Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Service Provider, 2024
Figure 4 : Global Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Service Type, 2024
Figure 5 : Global Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Product Type, 2024
Figure 6 : Global Market Shares for Validation, Calibration, and Standardization in Life Sciences, by End User, 2024
Figure 7 : Global Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Region, 2024
Figure 8 : North American Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Country, 2024
Figure 9 : European Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Country, 2024
Figure 10 : Asia-Pacific Market Shares for Validation, Calibration, and Standardization in Life Sciences, by Country, 2024
Figure 11 : Advantest Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 12 : Dassault Systemes: Revenue Shares, by Country/Region, FY 2024
Figure 13 : Endress+Hauser Group Services AG: Revenue Shares, by Country/Region, FY 2024
Figure 14 : Harvard Bioscience Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 15 : IBM Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 16 : IBM Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 17 : SGS Societe Generale de Surveillance SA: Revenue Shares, by Business Unit, FY 2024
Figure 18 : SGS Societe Generale de Surveillance SA: Revenue Shares, by Country/Region, FY 2024
Figure 19 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 20 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 21 : Transcat Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 22 : Transcat Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 23 : Vaisala: Revenue Shares, by Business Unit, FY 2024
Figure 24 : Vaisala: Revenue Shares, by Country/Region, FY 2024

Validation, Calibration, and Standardization in the Life Sciences Market

Description

Table of Contents

List of Tables

Report Scope

Report Includes

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Regulatory Landscape

Chapter 5 Emerging Technologies and Developments

Chapter 6 Market Segmentation Analysis

Chapter 7 Competitive Intelligence

Chapter 8 Appendix

List of Tables

List of Figures